UBS: Gives Zijin Mining Group (02899) a "buy" rating with a target price of 22.3 Hong Kong dollars.
Zijin Mining's net profit attributable to shareholders for the fiscal year 2024 increased by 51.5% year-on-year, which is basically in line with market and bank expectations.
UBS released a research report stating that it has given a "buy" rating to Zijin Mining Group (02899). Due to a downward revision in production guidance by Zijin, it is expected that investors will have a slightly negative reaction. The target price is set at 22.3 Hong Kong dollars.
Zijin Mining Group's net profit attributable to shareholders for fiscal year 2024 increased by 51.5% year-on-year, which is basically in line with market and the bank's expectations. During the period, copper production increased by 6% year-on-year, slightly below the full-year expectation; gold production increased by 8% year-on-year, which is basically in line with the full-year expectation. Zijin has lowered its copper production guidance for 2025 from 1.22 million tonnes to 1.15 million tonnes, while maintaining the gold production guidance unchanged.
Related Articles

On November 4th, STANCHART (02888) spent 7.606 million pounds to repurchase 481,000 shares.

KML TECH (08065) issues profit warning, expecting a mid-term pre-tax loss of approximately HK$4.5 million.

HAOHAI BIOTEC (06826) spent HK$805,700 to repurchase 29,600 shares on November 5th.
On November 4th, STANCHART (02888) spent 7.606 million pounds to repurchase 481,000 shares.

KML TECH (08065) issues profit warning, expecting a mid-term pre-tax loss of approximately HK$4.5 million.

HAOHAI BIOTEC (06826) spent HK$805,700 to repurchase 29,600 shares on November 5th.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


